Xspray Pharma AB (publ) XSPRAY.ST
XSPRAY.ST
Xspray Pharma AB (publ) ONCO.ST
Oncopeptides AB (publ) SYNACT.ST
SynAct Pharma AB ITECH.ST
I-Tech AB IBT-B.ST
Infant Bacterial Therapeutics AB (publ) CANTA.ST
Cantargia AB (publ) SEZI.ST
Senzime AB (publ) CRAD-B.ST
C-Rad AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) GENO.ST
Genovis AB (publ.)
Xspray Pharma AB (publ) ONCO.ST
Oncopeptides AB (publ) SYNACT.ST
SynAct Pharma AB ITECH.ST
I-Tech AB IBT-B.ST
Infant Bacterial Therapeutics AB (publ) CANTA.ST
Cantargia AB (publ) SEZI.ST
Senzime AB (publ) CRAD-B.ST
C-Rad AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) GENO.ST
Genovis AB (publ.)
Performance
| Periode | XSPRAY.ST | ONCO.ST | SYNACT.ST | ITECH.ST | IBT-B.ST | CANTA.ST | SEZI.ST | CRAD-B.ST | DMYD-B.ST | GENO.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -28.90 % | 163.45 % | 15.26 % | -8.27 % | 25.52 % | 54.46 % | 26.86 % | 11.68 % | 40.97 % | 13.18 % |
| YTD | -41.02 % | 228.48 % | 127.81 % | 22.00 % | 5.40 % | 42.65 % | 2.11 % | 11.49 % | -37.28 % | -6.76 % |
| 1Y | -55.86 % | 151.94 % | 139.60 % | 48.18 % | 73.85 % | -21.01 % | -4.44 % | -9.84 % | -19.67 % | 1.56 % |
| 3Y | -55.26 % | -41.22 % | -56.62 % | 48.18 % | 7.84 % | -34.00 % | -28.18 % | -5.98 % | -18.51 % | -38.51 % |
| 5Y | -80.99 % | -95.69 % | -54.09 % | 4.87 % | -59.07 % | -95.67 % | -73.23 % | -18.72 % | -67.82 % | -26.02 % |
| 10Y | -17.36 % | -83.06 % | 326.76 % | 196.72 % | 3.48 % | -69.40 % | 61.60 % | 83.61 % | 76.03 % | 1 238.24 % |
| Depuis le début | -17.36 % | -83.06 % | 326.76 % | 196.72 % | 3.48 % | -71.44 % | -13.01 % | 131.66 % | 225.83 % | -53.52 % |